European Patent Office

T 0259/15 (Buprenorphine patch/EURO-CELTIQUE) of 25.07.2017

European Case Law Identifier
ECLI:EP:BA:2017:T025915.20170725
Date of decision
25 July 2017
Case number
T 0259/15
Petition for review of
-
Application number
10185240.8
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
A buprenorphine transdermal patch for use in the treatment of pain for a dosing interval of at least 7 days
Applicant name
EURO-CELTIQUE S.A.
Mundipharma Laboratories GmbH
Napp Pharmaceutical Holdings Limited
Mundipharma Pharmaceuticals B.V.
Mundipharma AB
Mundipharma Pharmaceuticals Limited
Norpharma A/S
Mundipharma OY
Opponent name
Gallafent, Alison
Hexal AG
Murray, Adrian D'Coligny
tesa Labtec GmbH
Board
3.3.07
Headnote
-
Relevant legal provisions
European Patent Convention Art 56
Keywords
Inventive step - (no)
Catchword
-
Citing cases
T 0489/20

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.